Table 16.
Results of the paired t-test, SES, SRM in the validation phase (N = 163, age>7)
| |
Baseline |
Week 12 |
Difference between before and after treatment |
SES | SRM | |||
|---|---|---|---|---|---|---|---|---|
| x - ± SD | x - ± SD | x - ± SD | P | T | 95% CI | |||
| Primary bothersome symptom |
7.00 ± 2.27 |
3.87 ± 2.52 |
3.13 ± 2.97 |
<0.001 |
13.45 |
2.67-3.59 |
1.38 |
1.05 |
| Secondary bothersome symptom |
6.37 ± 2.38 |
3.42 ± 2.45 |
2.95 ± 2.96 |
<0.001 |
12.72 |
2.49-3.41 |
1.24 |
1.00 |
| ZRADSQ |
15.12 ± 6.58 |
8.63 ± 5.66 |
6.48 ± 6.14 |
<0.001 |
13.48 |
5.53-7.43 |
0.98 |
1.06 |
| SCORAD | 48.34 ± 15.66 | 26.97 ± 15.76 | 21.36 ± 15.22 | <0.001 | 17.93 | 19.01-23.72 | 1.36 | 1.40 |